APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Aurora Kinase B

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Aurora Kinase B Market Outlook and Growth Opportunities 2026

Report ID 173968300419 December 2025192 pages

Choose your research edition.

Industry ResearchAurora Kinase B Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Aurora Kinase B Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Aurora Kinase B Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Aurora Kinase B Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Aurora Kinase B Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Aurora Kinase B market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Aurora Kinase B is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Aurora Kinase B is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Aurora Kinase B is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Aurora Kinase B market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Aurora Kinase B market include Advenchen Laboratories LLC, Aeterna Zentaris Inc, Chipscreen Biosciences Ltd, Cielo Therapeutics Inc, Sareum Holdings Plc, AstraZeneca Plc, AbbVie Inc, Amgen Inc and Sanofi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Aurora Kinase B market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Aurora Kinase B and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Aurora Kinase B sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Aurora Kinase B market size, projected growth trends, production technologies, key applications, and end-use industries.

Aurora Kinase B Segment by Company

Advenchen Laboratories LLC

Aeterna Zentaris Inc

Chipscreen Biosciences Ltd

Cielo Therapeutics Inc

Sareum Holdings Plc

AstraZeneca Plc

AbbVie Inc

Amgen Inc

Sanofi

Aurora Kinase B Segment by Type

Danusertib

NMI-900

Ilorasertib

CS-2164

AZD-2811

Others

Aurora Kinase B Segment by Application

Kidney Cancer

Prostate Cancer

Anaplastic Large Cell Lymphoma

Lung Cancer

Others

Aurora Kinase B Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Aurora Kinase B status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Aurora Kinase B market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Aurora Kinase B significant trends, drivers, influence factors in global and regions.

6. To analyze Aurora Kinase B competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Aurora Kinase B market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Aurora Kinase B and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Aurora Kinase B.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Aurora Kinase B market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Aurora Kinase B industry.

Chapter 3: Detailed analysis of Aurora Kinase B manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Aurora Kinase B in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Aurora Kinase B in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Aurora Kinase B Industry Trends Table 2. Aurora Kinase B Industry Drivers Table 3. Aurora Kinase B Industry Opportunities and Challenges Table 4. Aurora Kinase B Industry Restraints Table 5. Global Aurora Kinase B Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Aurora Kinase B Revenue Share by Company (2021-2026) Table 7. Global Aurora Kinase B Sales Volume by Company (W Units) & (2021-2026) Table 8. Global Aurora Kinase B Sales Volume Share by Company (2021-2026) Table 9. Global Aurora Kinase B Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Aurora Kinase B Company Ranking, (2024-2026) & (USD Million) Table 11. Global Aurora Kinase B Key Company Manufacturing Base & Headquarters Table 12. Global Aurora Kinase B Company, Product Type & Application Table 13. Global Aurora Kinase B Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Aurora Kinase B by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Danusertib Table 18. Significant Companies of NMI-900 Table 19. Significant Companies of Ilorasertib Table 20. Significant Companies of CS-2164 Table 21. Significant Companies of AZD-2811 Table 22. Significant Companies of Others Table 23. Global Aurora Kinase B Sales Volume by Type 2021 VS 2025 VS 2032 (W Units) Table 24. Global Aurora Kinase B Sales Volume by Type (2021-2026) & (W Units) Table 25. Global Aurora Kinase B Sales Volume by Type (2027-2032) & (W Units) Table 26. Global Aurora Kinase B Sales Volume Share by Type (2021-2026) Table 27. Global Aurora Kinase B Sales Volume Share by Type (2027-2032) Table 28. Global Aurora Kinase B Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Aurora Kinase B Sales Value by Type (2021-2026) & (US$ Million) Table 30. Global Aurora Kinase B Sales Value by Type (2027-2032) & (US$ Million) Table 31. Global Aurora Kinase B Sales Value Share by Type (2021-2026) Table 32. Global Aurora Kinase B Sales Value Share by Type (2027-2032) Table 33. Significant Companies of Kidney Cancer Table 34. Significant Companies of Prostate Cancer Table 35. Significant Companies of Anaplastic Large Cell Lymphoma Table 36. Significant Companies of Lung Cancer Table 37. Significant Companies of Others Table 38. Global Aurora Kinase B Sales Volume by Application 2021 VS 2025 VS 2032 (W Units) Table 39. Global Aurora Kinase B Sales Volume by Application (2021-2026) & (W Units) Table 40. Global Aurora Kinase B Sales Volume by Application (2027-2032) & (W Units) Table 41. Global Aurora Kinase B Sales Volume Share by Application (2021-2026) Table 42. Global Aurora Kinase B Sales Volume Share by Application (2027-2032) Table 43. Global Aurora Kinase B Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 44. Global Aurora Kinase B Sales Value by Application (2021-2026) & (US$ Million) Table 45. Global Aurora Kinase B Sales Value by Application (2027-2032) & (US$ Million) Table 46. Global Aurora Kinase B Sales Value Share by Application (2021-2026) Table 47. Global Aurora Kinase B Sales Value Share by Application (2027-2032) Table 48. Global Aurora Kinase B Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 49. Global Aurora Kinase B Sales by Region (2021-2026) & (W Units) Table 50. Global Aurora Kinase B Sales Market Share by Region (2021-2026) Table 51. Global Aurora Kinase B Sales by Region (2027-2032) & (W Units) Table 52. Global Aurora Kinase B Sales Market Share by Region (2027-2032) Table 53. Global Aurora Kinase B Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 54. Global Aurora Kinase B Sales Value by Region (2021-2026) & (US$ Million) Table 55. Global Aurora Kinase B Sales Value Share by Region (2021-2026) Table 56. Global Aurora Kinase B Sales Value by Region (2027-2032) & (US$ Million) Table 57. Global Aurora Kinase B Sales Value Share by Region (2027-2032) Table 58. Global Aurora Kinase B Market Average Price (US$/Unit) by Region (2021-2026) Table 59. Global Aurora Kinase B Market Average Price (US$/Unit) by Region (2027-2032) Table 60. Global Aurora Kinase B Sales by Country: 2021 VS 2025 VS 2032 (W Units) Table 61. Global Aurora Kinase B Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Aurora Kinase B Sales by Country (2021-2026) & (W Units) Table 63. Global Aurora Kinase B Sales Market Share by Country (2021-2026) Table 64. Global Aurora Kinase B Sales by Country (2027-2032) & (W Units) Table 65. Global Aurora Kinase B Sales Market Share by Country (2027-2032) Table 66. Global Aurora Kinase B Sales Value by Country (2021-2026) & (US$ Million) Table 67. Global Aurora Kinase B Sales Value Market Share by Country (2021-2026) Table 68. Global Aurora Kinase B Sales Value by Country (2027-2032) & (US$ Million) Table 69. Global Aurora Kinase B Sales Value Market Share by Country (2027-2032) Table 70. Advenchen Laboratories LLC Company Information Table 71. Advenchen Laboratories LLC Business Overview Table 72. Advenchen Laboratories LLC Aurora Kinase B Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Advenchen Laboratories LLC Aurora Kinase B Product Portfolio Table 74. Advenchen Laboratories LLC Recent Development Table 75. Aeterna Zentaris Inc Company Information Table 76. Aeterna Zentaris Inc Business Overview Table 77. Aeterna Zentaris Inc Aurora Kinase B Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Aeterna Zentaris Inc Aurora Kinase B Product Portfolio Table 79. Aeterna Zentaris Inc Recent Development Table 80. Chipscreen Biosciences Ltd Company Information Table 81. Chipscreen Biosciences Ltd Business Overview Table 82. Chipscreen Biosciences Ltd Aurora Kinase B Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Chipscreen Biosciences Ltd Aurora Kinase B Product Portfolio Table 84. Chipscreen Biosciences Ltd Recent Development Table 85. Cielo Therapeutics Inc Company Information Table 86. Cielo Therapeutics Inc Business Overview Table 87. Cielo Therapeutics Inc Aurora Kinase B Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Cielo Therapeutics Inc Aurora Kinase B Product Portfolio Table 89. Cielo Therapeutics Inc Recent Development Table 90. Sareum Holdings Plc Company Information Table 91. Sareum Holdings Plc Business Overview Table 92. Sareum Holdings Plc Aurora Kinase B Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Sareum Holdings Plc Aurora Kinase B Product Portfolio Table 94. Sareum Holdings Plc Recent Development Table 95. AstraZeneca Plc Company Information Table 96. AstraZeneca Plc Business Overview Table 97. AstraZeneca Plc Aurora Kinase B Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. AstraZeneca Plc Aurora Kinase B Product Portfolio Table 99. AstraZeneca Plc Recent Development Table 100. AbbVie Inc Company Information Table 101. AbbVie Inc Business Overview Table 102. AbbVie Inc Aurora Kinase B Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. AbbVie Inc Aurora Kinase B Product Portfolio Table 104. AbbVie Inc Recent Development Table 105. Amgen Inc Company Information Table 106. Amgen Inc Business Overview Table 107. Amgen Inc Aurora Kinase B Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Amgen Inc Aurora Kinase B Product Portfolio Table 109. Amgen Inc Recent Development Table 110. Sanofi Company Information Table 111. Sanofi Business Overview Table 112. Sanofi Aurora Kinase B Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Sanofi Aurora Kinase B Product Portfolio Table 114. Sanofi Recent Development Table 115. Key Raw Materials Table 116. Raw Materials Key Suppliers Table 117. Aurora Kinase B Distributors List Table 118. Aurora Kinase B Customers List Table 119. Research Programs/Design for This Report Table 120. Authors List of This Report Table 121. Secondary Sources Table 122. Primary Sources List of Figures Figure 1. Aurora Kinase B Product Image Figure 2. Global Aurora Kinase B Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Aurora Kinase B Sales Value (2021-2032) & (US$ Million) Figure 4. Global Aurora Kinase B Sales (2021-2032) & (W Units) Figure 5. Global Aurora Kinase B Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Aurora Kinase B Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Danusertib Image Figure 10. NMI-900 Image Figure 11. Ilorasertib Image Figure 12. CS-2164 Image Figure 13. AZD-2811 Image Figure 14. Others Image Figure 15. Global Aurora Kinase B Sales Volume by Type (2021 VS 2025 VS 2032) & (W Units) Figure 16. Global Aurora Kinase B Sales Volume Share 2021 VS 2025 VS 2032 Figure 17. Global Aurora Kinase B Sales Volume Share by Type (2021-2032) Figure 18. Global Aurora Kinase B Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Aurora Kinase B Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Aurora Kinase B Sales Value Share by Type (2021-2032) Figure 21. Kidney Cancer Image Figure 22. Prostate Cancer Image Figure 23. Anaplastic Large Cell Lymphoma Image Figure 24. Lung Cancer Image Figure 25. Others Image Figure 26. Global Aurora Kinase B Sales Volume by Application (2021 VS 2025 VS 2032) & (W Units) Figure 27. Global Aurora Kinase B Sales Volume Share 2021 VS 2025 VS 2032 Figure 28. Global Aurora Kinase B Sales Volume Share by Application (2021-2032) Figure 29. Global Aurora Kinase B Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Aurora Kinase B Sales Value Share 2021 VS 2025 VS 2032 Figure 31. Global Aurora Kinase B Sales Value Share by Application (2021-2032) Figure 32. Global Aurora Kinase B Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 33. Global Aurora Kinase B Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 34. Global Aurora Kinase B Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 35. Global Aurora Kinase B Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 36. North America Aurora Kinase B Sales Value (2021-2032) & (US$ Million) Figure 37. North America Aurora Kinase B Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Europe Aurora Kinase B Sales Value (2021-2032) & (US$ Million) Figure 39. Europe Aurora Kinase B Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Asia-Pacific Aurora Kinase B Sales Value (2021-2032) & (US$ Million) Figure 41. Asia-Pacific Aurora Kinase B Sales Value Share by Country (%), 2025 VS 2032 Figure 42. South America Aurora Kinase B Sales Value (2021-2032) & (US$ Million) Figure 43. South America Aurora Kinase B Sales Value Share by Country (%), 2025 VS 2032 Figure 44. Middle East & Africa Aurora Kinase B Sales Value (2021-2032) & (US$ Million) Figure 45. Middle East & Africa Aurora Kinase B Sales Value Share by Country (%), 2025 VS 2032 Figure 46. USA Aurora Kinase B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. USA Aurora Kinase B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. USA Aurora Kinase B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Canada Aurora Kinase B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Canada Aurora Kinase B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Canada Aurora Kinase B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Mexico Aurora Kinase B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Mexico Aurora Kinase B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Mexico Aurora Kinase B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Germany Aurora Kinase B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Germany Aurora Kinase B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Germany Aurora Kinase B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. France Aurora Kinase B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. France Aurora Kinase B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. France Aurora Kinase B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. U.K. Aurora Kinase B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. U.K. Aurora Kinase B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. U.K. Aurora Kinase B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Italy Aurora Kinase B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Italy Aurora Kinase B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Italy Aurora Kinase B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Spain Aurora Kinase B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Spain Aurora Kinase B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Spain Aurora Kinase B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Russia Aurora Kinase B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Russia Aurora Kinase B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Russia Aurora Kinase B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Netherlands Aurora Kinase B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Netherlands Aurora Kinase B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Netherlands Aurora Kinase B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Nordic Countries Aurora Kinase B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Nordic Countries Aurora Kinase B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Nordic Countries Aurora Kinase B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. China Aurora Kinase B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. China Aurora Kinase B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. China Aurora Kinase B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Japan Aurora Kinase B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Japan Aurora Kinase B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Japan Aurora Kinase B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. South Korea Aurora Kinase B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. South Korea Aurora Kinase B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. South Korea Aurora Kinase B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. India Aurora Kinase B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. India Aurora Kinase B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. India Aurora Kinase B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Australia Aurora Kinase B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Australia Aurora Kinase B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Australia Aurora Kinase B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Southeast Asia Aurora Kinase B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Southeast Asia Aurora Kinase B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Southeast Asia Aurora Kinase B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Brazil Aurora Kinase B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Brazil Aurora Kinase B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Brazil Aurora Kinase B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Argentina Aurora Kinase B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Argentina Aurora Kinase B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Argentina Aurora Kinase B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Chile Aurora Kinase B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Chile Aurora Kinase B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Chile Aurora Kinase B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Colombia Aurora Kinase B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Colombia Aurora Kinase B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Colombia Aurora Kinase B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Peru Aurora Kinase B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Peru Aurora Kinase B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Peru Aurora Kinase B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Saudi Arabia Aurora Kinase B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Saudi Arabia Aurora Kinase B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Saudi Arabia Aurora Kinase B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Israel Aurora Kinase B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Israel Arabia Aurora Kinase B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Israel Arabia Aurora Kinase B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. UAE Aurora Kinase B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. UAE Aurora Kinase B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. UAE Aurora Kinase B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Turkey Aurora Kinase B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Turkey Aurora Kinase B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Turkey Aurora Kinase B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Iran Aurora Kinase B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Iran Aurora Kinase B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Iran Aurora Kinase B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Egypt Aurora Kinase B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 128. Egypt Aurora Kinase B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 129. Egypt Aurora Kinase B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 130. Aurora Kinase B Value Chain Figure 131. Manufacturing Cost Structure Figure 132. Aurora Kinase B Sales Mode & Process Figure 133. Direct Comparison with Distribution Share Figure 134. Distributors Profiles Figure 135. Years Considered Figure 136. Research Process Figure 137. Key Executives Interviewed

Scope & coverage.

Types
  • Danusertib
  • NMI-900
  • Ilorasertib
  • CS-2164
  • AZD-2811
  • Others
Applications
  • Kidney Cancer
  • Prostate Cancer
  • Anaplastic Large Cell Lymphoma
  • Lung Cancer
  • Others
Companies covered
  • Advenchen Laboratories LLC
  • Aeterna Zentaris Inc
  • Chipscreen Biosciences Ltd
  • Cielo Therapeutics Inc
  • Sareum Holdings Plc
  • AstraZeneca Plc
  • AbbVie Inc
  • Amgen Inc
  • Sanofi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Aurora Kinase B Sales Value (2021-2032)
  4. 1.2.2 Global Aurora Kinase B Sales Volume (2021-2032)
  5. 1.2.3 Global Aurora Kinase B Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Aurora Kinase B Market Dynamics
  1. 2.1 Aurora Kinase B Industry Trends
  2. 2.2 Aurora Kinase B Industry Drivers
  3. 2.3 Aurora Kinase B Industry Opportunities and Challenges
  4. 2.4 Aurora Kinase B Industry Restraints
3 Aurora Kinase B Market by Company
  1. 3.1 Global Aurora Kinase B Company Revenue Ranking in 2025
  2. 3.2 Global Aurora Kinase B Revenue by Company (2021-2026)
  3. 3.3 Global Aurora Kinase B Sales Volume by Company (2021-2026)
  4. 3.4 Global Aurora Kinase B Average Price by Company (2021-2026)
  5. 3.5 Global Aurora Kinase B Company Ranking (2024-2026)
  6. 3.6 Global Aurora Kinase B Company Manufacturing Base and Headquarters
  7. 3.7 Global Aurora Kinase B Company Product Type and Application
  8. 3.8 Global Aurora Kinase B Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Aurora Kinase B Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Aurora Kinase B Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Aurora Kinase B Market by Type
  1. 4.1 Aurora Kinase B Type Introduction
  2. 4.1.1 Danusertib
  3. 4.1.2 NMI-900
  4. 4.1.3 Ilorasertib
  5. 4.1.4 CS-2164
  6. 4.1.5 AZD-2811
  7. 4.1.6 Others
  8. 4.2 Global Aurora Kinase B Sales Volume by Type
  9. 4.2.1 Global Aurora Kinase B Sales Volume by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Aurora Kinase B Sales Volume by Type (2021-2032)
  11. 4.2.3 Global Aurora Kinase B Sales Volume Share by Type (2021-2032)
  12. 4.3 Global Aurora Kinase B Sales Value by Type
  13. 4.3.1 Global Aurora Kinase B Sales Value by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Aurora Kinase B Sales Value by Type (2021-2032)
  15. 4.3.3 Global Aurora Kinase B Sales Value Share by Type (2021-2032)
5 Aurora Kinase B Market by Application
  1. 5.1 Aurora Kinase B Application Introduction
  2. 5.1.1 Kidney Cancer
  3. 5.1.2 Prostate Cancer
  4. 5.1.3 Anaplastic Large Cell Lymphoma
  5. 5.1.4 Lung Cancer
  6. 5.1.5 Others
  7. 5.2 Global Aurora Kinase B Sales Volume by Application
  8. 5.2.1 Global Aurora Kinase B Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Aurora Kinase B Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Aurora Kinase B Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Aurora Kinase B Sales Value by Application
  12. 5.3.1 Global Aurora Kinase B Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Aurora Kinase B Sales Value by Application (2021-2032)
  14. 5.3.3 Global Aurora Kinase B Sales Value Share by Application (2021-2032)
6 Aurora Kinase B Regional Sales and Value Analysis
  1. 6.1 Global Aurora Kinase B Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Aurora Kinase B Sales by Region (2021-2032)
  3. 6.2.1 Global Aurora Kinase B Sales by Region: 2021-2026
  4. 6.2.2 Global Aurora Kinase B Sales by Region (2027-2032)
  5. 6.3 Global Aurora Kinase B Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Aurora Kinase B Sales Value by Region (2021-2032)
  7. 6.4.1 Global Aurora Kinase B Sales Value by Region: 2021-2026
  8. 6.4.2 Global Aurora Kinase B Sales Value by Region (2027-2032)
  9. 6.5 Global Aurora Kinase B Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Aurora Kinase B Sales Value (2021-2032)
  12. 6.6.2 North America Aurora Kinase B Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Aurora Kinase B Sales Value (2021-2032)
  15. 6.7.2 Europe Aurora Kinase B Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Aurora Kinase B Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Aurora Kinase B Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Aurora Kinase B Sales Value (2021-2032)
  21. 6.9.2 South America Aurora Kinase B Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Aurora Kinase B Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Aurora Kinase B Sales Value Share by Country, 2025 VS 2032
7 Aurora Kinase B Country-level Sales and Value Analysis
  1. 7.1 Global Aurora Kinase B Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Aurora Kinase B Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Aurora Kinase B Sales by Country (2021-2032)
  4. 7.3.1 Global Aurora Kinase B Sales by Country (2021-2026)
  5. 7.3.2 Global Aurora Kinase B Sales by Country (2027-2032)
  6. 7.4 Global Aurora Kinase B Sales Value by Country (2021-2032)
  7. 7.4.1 Global Aurora Kinase B Sales Value by Country (2021-2026)
  8. 7.4.2 Global Aurora Kinase B Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Aurora Kinase B Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Aurora Kinase B Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Aurora Kinase B Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Aurora Kinase B Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Aurora Kinase B Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Aurora Kinase B Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Aurora Kinase B Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Aurora Kinase B Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Aurora Kinase B Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Aurora Kinase B Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Aurora Kinase B Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Aurora Kinase B Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Aurora Kinase B Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Aurora Kinase B Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Aurora Kinase B Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Aurora Kinase B Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Aurora Kinase B Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Aurora Kinase B Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Aurora Kinase B Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Aurora Kinase B Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Aurora Kinase B Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Aurora Kinase B Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Aurora Kinase B Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Aurora Kinase B Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Aurora Kinase B Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Aurora Kinase B Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Aurora Kinase B Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Aurora Kinase B Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Aurora Kinase B Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Aurora Kinase B Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Aurora Kinase B Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Aurora Kinase B Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Aurora Kinase B Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Aurora Kinase B Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Aurora Kinase B Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Aurora Kinase B Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Aurora Kinase B Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Aurora Kinase B Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Aurora Kinase B Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Aurora Kinase B Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Aurora Kinase B Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Aurora Kinase B Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Aurora Kinase B Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Aurora Kinase B Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Aurora Kinase B Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Aurora Kinase B Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Aurora Kinase B Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Aurora Kinase B Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Aurora Kinase B Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Aurora Kinase B Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Aurora Kinase B Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Aurora Kinase B Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Aurora Kinase B Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Aurora Kinase B Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Aurora Kinase B Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Aurora Kinase B Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Aurora Kinase B Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Aurora Kinase B Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Aurora Kinase B Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Aurora Kinase B Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Aurora Kinase B Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Aurora Kinase B Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Aurora Kinase B Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Aurora Kinase B Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Aurora Kinase B Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Aurora Kinase B Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Aurora Kinase B Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Aurora Kinase B Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Aurora Kinase B Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Aurora Kinase B Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Aurora Kinase B Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Aurora Kinase B Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Aurora Kinase B Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Aurora Kinase B Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Aurora Kinase B Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Aurora Kinase B Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Aurora Kinase B Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Aurora Kinase B Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Aurora Kinase B Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Aurora Kinase B Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Aurora Kinase B Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Aurora Kinase B Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Aurora Kinase B Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Aurora Kinase B Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Advenchen Laboratories LLC
  2. 8.1.1 Advenchen Laboratories LLC Company Information
  3. 8.1.2 Advenchen Laboratories LLC Business Overview
  4. 8.1.3 Advenchen Laboratories LLC Aurora Kinase B Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Advenchen Laboratories LLC Aurora Kinase B Product Portfolio
  6. 8.1.5 Advenchen Laboratories LLC Recent Developments
  7. 8.2 Aeterna Zentaris Inc
  8. 8.2.1 Aeterna Zentaris Inc Company Information
  9. 8.2.2 Aeterna Zentaris Inc Business Overview
  10. 8.2.3 Aeterna Zentaris Inc Aurora Kinase B Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Aeterna Zentaris Inc Aurora Kinase B Product Portfolio
  12. 8.2.5 Aeterna Zentaris Inc Recent Developments
  13. 8.3 Chipscreen Biosciences Ltd
  14. 8.3.1 Chipscreen Biosciences Ltd Company Information
  15. 8.3.2 Chipscreen Biosciences Ltd Business Overview
  16. 8.3.3 Chipscreen Biosciences Ltd Aurora Kinase B Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Chipscreen Biosciences Ltd Aurora Kinase B Product Portfolio
  18. 8.3.5 Chipscreen Biosciences Ltd Recent Developments
  19. 8.4 Cielo Therapeutics Inc
  20. 8.4.1 Cielo Therapeutics Inc Company Information
  21. 8.4.2 Cielo Therapeutics Inc Business Overview
  22. 8.4.3 Cielo Therapeutics Inc Aurora Kinase B Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Cielo Therapeutics Inc Aurora Kinase B Product Portfolio
  24. 8.4.5 Cielo Therapeutics Inc Recent Developments
  25. 8.5 Sareum Holdings Plc
  26. 8.5.1 Sareum Holdings Plc Company Information
  27. 8.5.2 Sareum Holdings Plc Business Overview
  28. 8.5.3 Sareum Holdings Plc Aurora Kinase B Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Sareum Holdings Plc Aurora Kinase B Product Portfolio
  30. 8.5.5 Sareum Holdings Plc Recent Developments
  31. 8.6 AstraZeneca Plc
  32. 8.6.1 AstraZeneca Plc Company Information
  33. 8.6.2 AstraZeneca Plc Business Overview
  34. 8.6.3 AstraZeneca Plc Aurora Kinase B Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 AstraZeneca Plc Aurora Kinase B Product Portfolio
  36. 8.6.5 AstraZeneca Plc Recent Developments
  37. 8.7 AbbVie Inc
  38. 8.7.1 AbbVie Inc Company Information
  39. 8.7.2 AbbVie Inc Business Overview
  40. 8.7.3 AbbVie Inc Aurora Kinase B Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 AbbVie Inc Aurora Kinase B Product Portfolio
  42. 8.7.5 AbbVie Inc Recent Developments
  43. 8.8 Amgen Inc
  44. 8.8.1 Amgen Inc Company Information
  45. 8.8.2 Amgen Inc Business Overview
  46. 8.8.3 Amgen Inc Aurora Kinase B Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Amgen Inc Aurora Kinase B Product Portfolio
  48. 8.8.5 Amgen Inc Recent Developments
  49. 8.9 Sanofi
  50. 8.9.1 Sanofi Company Information
  51. 8.9.2 Sanofi Business Overview
  52. 8.9.3 Sanofi Aurora Kinase B Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Sanofi Aurora Kinase B Product Portfolio
  54. 8.9.5 Sanofi Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Aurora Kinase B Value Chain Analysis
  2. 9.1.1 Aurora Kinase B Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Aurora Kinase B Sales Mode & Process
  6. 9.2 Aurora Kinase B Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Aurora Kinase B Distributors
  9. 9.2.3 Aurora Kinase B Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst